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PURPOSE. Uveal melanoma (UM) is the most common primary intraocular malignancy in adults
and approximately half of those diagnosed will die of metastasis. This study investigates
whether UM progression is driven by a subpopulation of stem-like cells, termed ‘‘cancer stem
cells’’ (CSCs).
METHODS. Expression of postulated stem cell markers aldehyde dehydrogenase (ALDH), CD44,
and CD133 was analyzed in UM cell lines and primary UM short-term cultures (STCs)
established from tumor samples. Additionally, the notion of a ‘‘cellular hierarchy’’ within UM
was investigated. Finally, the phenomenon of phenotypic plasticity in response to
environmental factors was explored.
RESULTS. We demonstrate that expression of ALDH, CD44, and CD133 does not select for a
subpopulation of stem-like cells in either UM cell lines or UM STCs. Furthermore, there is an
absence of a cellular hierarchy in cell lines and all cells in culture are able to drive tumor
progression. Last, we show that established UM cell lines and UM STCs are plastic in nature
and switch their phenotype in response to environmental stimuli.
CONCLUSIONS. We hypothesize that this capacity to undergo phenotypic plasticity may be a
consequence of neural crest lineage and renders the exploration of the CSC hypothesis
extremely challenging in UM.
Keywords: uveal melanoma, cancer stem cells, cellular hierarchy, phenotypic plasticity
Uveal melanoma (UM) is the most common primaryintraocular malignancy in adults, accounting for 80% of
all noncutaneous melanoma.1 These tumors are often highly
aggressive and frequently metastasize to the liver, after which
point survival is rarely more than 6 months. Long-term
monitoring of UM patients has shown that liver metastasis
can develop decades after first diagnosis, suggesting that UM
cells remain dormant within the body for long periods.2 One
explanation for this apparent dormancy has been suggested by
the idea of cancer stem cells (CSCs) within tumors. The CSC
hypothesis of tumor progression states that all tumor cell types
arise from a rare subpopulation of multipotent CSCs that are
thought to be responsible for tumor initiation, progression, and
relapse posttreatment, and therefore need to be destroyed for
treatment to be successful long-term.3,4
Since the notion of the ‘‘cancer stem cell hypothesis’’ was
first presented in leukemic studies in the 1990s,5,6 there have
been considerable efforts to trace this rare cell of origin in solid
tumors.7–11 CSCs are characterized as tumor cells with similar
characteristics to normal stem cells, such as continual self-
renewal and the capacity to differentiate. Normal tissue is
organized in a cellular hierarchy whereby cells exhibit different
capacities to proliferate and differentiate.12 This was first
demonstrated in in vitro clonogenic studies in keratinocytes
whereby three distinct clone types were observed in culture,
termed ‘‘holoclones,’’ ‘‘meroclones,’’ and ‘‘paraclones.’’ Hol-
oclones were described as large, highly proliferative clones
made up of undifferentiated cells that, when isolated from
culture and reseeded, were able to reestablish holoclones,
meroclones, and paraclones. Meroclones were described as
partially differentiated, intermediate clones that gave rise to
further meroclones and paraclones, but were unable to give
rise to holoclones. Paraclones were seen to be small colonies
made up of cells with irregular morphologies. Paraclones were
unable to give rise to further colony types when isolated from
culture and therefore thought to represent terminally differen-
tiated cells. It has since been shown that several cancers are
organized in a similar fashion to normal tissue, in that cancer
cells also have varying capacities to proliferate and differentiate
and CSCs represent the apex of the cell hierarchy. A number of
established cancer cell lines have been shown to retain a stem
cell–like hierarchical structure reflective of the heterogeneity
observed in tumors.11,13–16
A number of studies in cutaneous melanoma (CM) support
the CSC hypothesis in this tumor type and have proposed
potential biomarkers for stem cells in cancers arising from a
melanocytic lineage, including cell surface markers, such as
CD133 and CD44, and markers associated with normal stem
cell function, such as aldehyde dehydrogenase (ALDH).17–20
Expression of the cell surface antigen CD44 has been shown to
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be present in tumor cells with enhanced self-renewal and
tumorigenic properties in a number of cancer types.9,21–23 In
an established CM cell line, CD44þ cells were seen to be more
metastatic in in vivo models compared with CD44 cells.24
Furthermore, ALDH expression has previously been shown to
select for tumorigenic subpopulations in CM cells isolated from
patient material.17 However, there are studies that negate these
findings and suggest that all CM cells are tumor-initiating and
exhibit stem-like characteristics, not just a subpopulation of
CSCs.25–27 Prasmickaite and colleagues27 found that low-
passage cell cultures established from metastatic CM exhibited
no difference in proliferative or clonogenic capacity between
ALDHþ or ALDH subpopulations.
The highly heterogeneous nature of all types of melanomas
and their propensity to metastasize are thought to be attributed
to their derivation from multipotent transitory neural crest
cells.28 Furthermore, there is evidence suggesting that these
cancer types are able to switch phenotypes, and depending on
conditions, are in fact fluid in their expression of stem cell
markers.25,29–32 Previous studies have demonstrated that CM
cells exhibit a phenomenon known as ‘‘phenotype switching,’’
whereby cells readily change between a differentiated state to a
dedifferentiated state dependent on their surroundings.33–36
This characteristic is thought to arise because melanocytes
originate from highly plastic, transitory neural crest cells. To
date, this phenomenon has not been shown in UM; however,
UM cells do exhibit various cell lineage markers, and are capable
of vasculogenic mimicry, suggesting a capacity to differentiate
into several cell types.37,38 The phenomenon of vasculogenic
mimicry, whereby tumor cells are able to recapitulate vascular
channels in the absence of endothelial cells or fibroblasts, has
been previously reported in CM and UM.39–41 Gene expression
profiling of both CM and UM cells capable of vasculogenic
mimicry showed that these cells express genes associated with
an undifferentiated phenotype.39,42 Furthermore CM cells have
been shown to be able to undergo dedifferentiation, which,
along with evidence of phenotype switching from vasculogenic
mimicry studies, renders the identification of true CSCs a
challenging prospect in melanoma.43
There have been limited studies investigating the CSC
hypothesis in UM. For example, Thill et al.44 reported the
presence of a subpopulation of CD133þ cells in UM cell lines;
however, their functional properties were not explored.
Furthermore, Kalirai et al.45 demonstrated the existence of a
hierarchical organization in two UM cell lines whereby
holoclones demonstrated indefinite self-renewal capacity and
increased chemoresistance. Studies of UM cell lines investigat-
ing the effect of growing cells as three-dimensional spheres in
comparison with two-dimensional monolayers showed that
expression of the CSC marker CD271 was dependent on
culture conditions and associated with the phenomenon of
vasculogenic mimicry.32
In this study, we initially sought to investigate the
expression of putative melanoma CSC markers ALDH, CD44,
and CD133 in UM cell lines and STCs, as well as in CM cell
lines. We subsequently analyzed both UM cell lines and tumor
cells at low passage number for their plasticity in response to
environmental stimulus and whether the phenomenon of
phenotype switching could be observed in UM, particularly in
STCs.
MATERIALS AND METHODS
Clinical Information
UM primary tumor samples were obtained from patients
undergoing enucleation at the Royal Hallamshire Hospital,
Sheffield, UK. Ethical approval and patient consent was sought
before surgery (09/ H1008/141) and the procedures adhered
to the tenets of the Declaration of Helsinki.
Cell Line Culture
UM cell lines SOM 157d and SOM 196b were previously
established from UM tissue cultured in the Academic Unit of
Ophthalmology and Orthoptics at the University of Sheffield.37
UM cell lines were cultured in ocular melanoma (Oc. Mel.)
medium consisting of RPMI medium (Invitrogen, Carlsbad,
California, USA) supplemented with 20% fetal calf serum (FCS),
100 U/mL penicillin, 100 lg/mL streptomycin, and 250 lg/mL
amphotericin B (Sigma Aldrich, St. Louis, MO, USA). Two CM
cell lines, A375 and WM793, were purchased from the
American Type Culture Collection (ATCC) (Manassas, VA,
USA) and cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% FCS, 100 U/mL penicillin, 100 lg/mL
streptomycin, and 250 lg/mL amphotericin B (Sigma Aldrich).
Establishment of UM Short-Term Cultures (STCs)
UM tumor pieces were collected immediately after surgery and
processed for culture by finely mincing as described previous-
ly.46 Once minced, the cell suspension was divided into two
T25 flasks and cultured independently in either Oc. Mel.
medium or in stem cell supportive medium termed ‘‘cancer
stem cell medium’’ (CSCM), a basal medium supplemented
with transferrin, insulin, and BSA (Provitro, Berlin, Germany).
Clonogenic Assay
Established cell lines were seeded out at 23 103 cells per 60-
mm dish and allowed to give rise to colonies over a period of
14 days. Classification of each colony was determined
depending on their morphology and capacity to give rise to
further colonies. Colonies were isolated from culture using 3-
mm clonal discs (Sigma Aldrich). Medium was removed and
plates washed with 1 3 PBS. Clonal discs were dipped in
trypsin and placed directly over isogenic colonies for 3
minutes. Discs were reseeded into individual wells of a six-
well plate containing fresh medium. Wells were checked for
the presence of colonies following 14 days in culture. The
percentage of successful colonies observed in comparison with
cells seeded (termed the ‘‘clonal efficiency’’) was calculated by
the following: (number of colonies observed/number of
colonies seeded) 3 100. Successful colonies were considered
to be those >0.5 mm in diameter after 14 days of culture.
Proliferation Assay
Cells were seeded into 96-well plates at either 1 3 103 cells
(established cell lines) or 2 3 103 cells (UM STCs) per well.
Cells were allowed to grow for 10 days at which point viable
cells were determined using trypan blue staining and the
number of cells per well was counted using a Vi-Cell XR cell
counter (Beckman Coulter, Brea, CA, USA). Experiments were
set up in six-well replicates and repeated three times.
Expression of ALDH and Isolation of ALDHþ Cells
Using Fluorescent-Activated Cell Sorting (FACS)
Cells were analyzed for ALDH activity using the Aldefluor assay
(Stem Cell Technologies, Vancouver, BC, Canada). The Alde-
fluor assay has been optimized to detect the ALDH1 isoform,
which is most related to stem cell function.47 Briefly, two tubes
containing 5 3 105 cells each were resuspended in Aldefluor
buffer and control cells incubated with 30 lM N,N-diethylami-
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nobenzaldehyde (DEAB) (a specific ALDH inhibitor) for 10
minutes before treatment with the Aldefluor substrate. Test
cells did not receive DEAB treatment. FACS for ALDH
expression was carried out following incubation with the
Aldefluor substrate using a FACSARIA (Becton Dickinson,
Oxford, UK). ALDHþ cells were identified as those cells
emitting fluorescence clearly greater than control inhibitor-
treated cells. ALDHþ and ALDH cell populations were seeded
into proliferation and clonogenic assays immediately after
sorting. To determine whether ALDH expression is a fixed
phenotype in CM, sorted ALDHþ cells and ALDH cells were
cultured for 14 days and subsequently reassessed for ALDH
activity using a FACSARIA (Becton Dickinson).
Expression of Stem Cell Surface Markers CD44 and
CD133
To determine expression of the stem cell surface markers
CD44 and CD133, cells were stained with anti-CD44 (PE-
conjugated) and anti-CD133 (APC-conjugated) antibodies
(Miltenyi, Begisch Gladbach, Germany). The anti-CD44 anti-
body detected all isoforms of CD44. An antibody against the
AC133 epitope of the CD133 antigen was used because this
specific epitope is expressed exclusively on stem and
progenitor cells and represents the glycosylation-dependent
epitope of CD133. Fluorophore-conjugated isotype control
antibodies were used in all experiments.
Briefly, two tubes containing 53 105 cells were centrifuged
and cell pellets were resuspended in blocking buffer before
antibody incubation. After incubation, cells were washed in
blocking buffer and fluorescent staining was visualized via flow
cytometry on a FACSCALIBUR (Becton Dickinson).
RESULTS
ALDH Activity in CM Cell Lines Does Not Select for
Increased Proliferative or Clonogenic Capacity
In the present study, both CM cell lines A375 and WM793 were
assessed for ALDH activity and the clonogenic and proliferative
capacity of subsequent ALDHþ and ALDH populations tested.
Both CM cell lines were seen to express ALDH in a high
percentage of cells in culture (Figs. 1A, 1B). The mean
percentage of ALDHþ A375 cells was 45.9% 6 13.4% (n¼ 3 6
SD) and 21.8% 6 9.7% (n¼ 3 6 SD) in WM793 cells. Following
identification of ALDHþ cells in both CM cell lines, cells were
sorted into ALDHþ and ALDH subpopulations and subsequently
seeded into proliferation and clonogenic assays. In both CM cell
lines, ALDHþ cells and ALDH sorted cells were found to
proliferate at an equivalent rate (Fig. 1C). When seeded out at
clonal density, ALDHþ and ALDH cells both readily formed
colonies. There was no significant difference in proliferative or
clonogenic capacity between ALDHþ and ALDH cells and no
difference in colony morphology observed (Fig. 1D).
ALDHþ and ALDH populations were reassessed for ALDH
expression 14 days post sort. Both A375 cells and WM793 cells
demonstrated that ALDH activity is a fluid process and mixed
populations of ALDHþ and ALDH cells were present in both
populations of previously sorted cells, summarized in the
Table. In the A375 cell line, the number of ALDHþ cells arising
from previously sorted ALDHþ cells was comparable to the
number of ALDHþ cells in unsorted populations (44.6% 6
1.7%). ALDH sorted populations were able to give rise to
daughter cells that expressed ALDH, although these ALDHþ
cells represented only 2.0% 6 0.1% of the population (n ¼ 3
6SD). In the WM793 cell line, previously sorted ALDHþ cells
largely retained their ALDHþ phenotype when grown in
culture, containing 85.8% 6 2.9% ALDHþ cells following 14
days in culture. Sorted ALDH WM793 cells also tended to
retain their original phenotype in culture, giving rise to only
2.6% 6 0.2% ALDHþ daughter cells.
ALDH Activity in UM Cell Lines and STCs Is Not
Associated With a Stem Cell Phenotype
Two UM cell lines and seven UM STCs were tested for
expression of ALDH. Interestingly, ALDH expression was absent
in both UM cell lines (n ¼ 3; data not shown). In contrast to
observations in UM cell lines, all UM STCs were found to contain
a subpopulation of ALDHþ cells ranging from 0.8% to 16.0%
(mean¼ 6%) (Fig. 1E). Where possible, repeats were performed;
however, due to limited material, this was not possible in all
cases. To determine whether expression of ALDH was related to
proliferation capacity, sorted populations were seeded into
proliferation assays. Four of seven UM STCs tested for ALDH
expression were taken forward for growth assays. We show that
there was no difference in the proliferative capacity of ALDHþ
cells versus ALDH cells in any of the four UM cases studied (Fig.
1F; data represent SOM 577).
CD133 Is Present in a Small Subpopulation of CM
Cells and Select UM STCs
In the present study, the two CM cell lines were seen to
contain small subpopulations of CD133þ cells (A375: mean of
0.6% [Fig. 2B]). WM793: mean of 0.3% (Fig. 2D; n¼ 3).
UM cell lines were found not to contain a subpopulation of
CD133þ cells (n ¼ 3; Figs. 2F, 2H). Of the six UM primary
cultures tested, only one (SOM 588) contained a subpopulation
of CD133þ cells (0.3% of cells) (Fig. 2J). The remaining five
cultures were negative for CD133 expression (data not shown).
Therefore, it was concluded that CD133 is not likely to
represent a CSC population in UM and was not studied further.
CD44 Is Highly Expressed in All Melanoma Cells
and Not Just a Minor Subpopulation
The present study found that in the two CM cell lines (>95%
CD44þ), and also the two UM cell lines (>95% CD44þ), CD44
was expressed in most cells in culture and not just a subset of
cells (Figs. 2A–G). Furthermore, CD44 was found to be
expressed in most cells in the six UM cultures tested, ranging
from 77% to 92% CD44þ cells (Fig. 2I; data represent SOM 588).
A Cellular Hierarchy Is Absent in Established UM
and CM Cell Lines
To determine whether UM cell lines SOM 157d and SOM 196b
were organized in a hierarchical manner, cells were seeded out
into clonogenic assays. Colonies were observed after 14 days.
The clonal efficiency for SOM 157d cells was 16.0% 6 0.4% and
13.0% 6 1.0% for SOM 196b (data represent the average colony
count and clonal efficiency of three repeat triplicate experiments
6 SEM). In both UM cell lines, colony morphologies remained
consistent with no variation in cell type or proliferative capacity
(Fig. 3). When isolated from culture using clonal discs, all
colonies picked and reseeded were able to reestablish further
colonies which resembled the parent colony. This observation
could be seen in all subsequent generations of colonies picked,
with 100% efficiency. There appears to be only one clone type
present in UM cell lines whereby every cell within the
population has the capacity to drive tumor progression.
To determine whether the CM cell lines, A375 and WM793,
reflect the clonal behavior of UM cell lines, cells were seeded
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out at clonal density in the same manner. A375 had an average
clonal efficiency of 16.0% 6 0.2%. WM793 had an average
clonal efficiency of 15.0% 6 0.6%. All colonies were seen to be
of a similar morphology and when isolated from culture all
colonies picked were able to reestablish subsequent colonies
resembling the parent colony for both A375 cells and WM793
cells, reflecting a similar colony-forming pattern as the UM cell
lines (data not shown).
UM Cells in Culture Exhibit a Highly Plastic
Phenotype and Switch Phenotypes Dependent on
Conditions
To investigate the effects of varying culture conditions on UM
cell behavior, we selected CSCM, as it is specifically optimized to
support a stem-like phenotype as a comparison to Oc. Mel.
TABLE. Plasticity of ALDH Expression in CM
Cell Line
% ALDHþ in
Unsorted
Population
% ALDHþ Arising
From ALDHþ
Population
% ALDHþ Arising
From ALDH
Population
A375 45.9 44.6 2.0
WM793 21.8 85.8 2.6
The number of ALDHþ A375 cells arising from sorted ALDHþ
populations was comparable to the number of ALDHþ cells in unsorted
populations (44.6% 6 1.7%). ALDH sorted populations were able to
give rise to ALDHþ daughter cells, although representing only 2.0% 6
0.1% of the population (n ¼ 3 6SD). In WM793 cells, ALDHþ cells
largely retained their ALDHþ phenotype, containing 85.8% 6 2.87%
ALDHþ cells following 14 days in culture. Sorted ALDH WM793 cells
also tended to retain their original phenotype in culture, giving rise to
2.6% 6 0.2% ALDHþ daughter cells 14 days post sort.
FIGURE 1. ALDH activity does not select for increased proliferative or clonogenic capacity in melanoma. Background fluorescence was determined
by treating a control population with the specific ALDH inhibitor DEAB in the presence of ALDH substrate. Gating for positive staining was
subsequently measured against inhibitor-treated control cells. Scatter plots of A375 (A) and WM793 (B) CM cell lines showing ALDHþ populations.
Mean percentage of ALDHþ population in A375 cells was 45.91% 6 13.35% (n ¼ 3 6SD) and 21.84% 6 9.69% (n ¼ 3 6SD) in WM793 cells. No
difference in proliferative (C) or clonogenic (D) capacity was observed between sorted ALDHþ or ALDH populations in either cell line. Of seven
UM STCs tested, ALDH expression was seen in all seven, ranging from 0.8% to 16% (E). No difference in proliferative capacity was observed
following sorting of ALDHþ and ALDH cells (data represent SOM 577) (F).
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FIGURE 2. Expression of stem cell markers CD44 and CD133. Control cells were stained with IgG antibodies to determine positive gating strategy.
CD44 was seen to be expressed in most cells in culture (A) A375 (>95% CD44þ cells), (C) WM793 (>95% CD44þ cells), (E) SOM 157d (>95%
CD44þ cells), (G) SOM 196b (>95% CD44þ cells), and (I) SOM 588 (>95% CD44þ cells). CD133þ cells represented a small subpopulation of cells in
CM cell lines. (B) A375 (0.62% CD133þcells) and (D) WM793 (0.32% CD133þ cells). CD133þ cells were absent in both UM cell lines (F) and (H);
however, a small subpopulation was detected in one of six UM STCS (J) SOM 588 (0.3% CD133þ cells). Data represent mean % positive cells, n¼ 3.
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medium. Tumor pieces were split, and half seeded into CSCM 
culture conditions and the other half seeded into Oc. 
Mel. medium. Thirteen STCs (see Supplementary Table S1 for 
clinical details) were observed over a period of 2 years 
and their morphology, melanin production, and proliferative 
rate moni-tored. Figure 4 demonstrates primary UM cells 
seeded directly into either Oc. Mel. medium (Fig. 4A) or 
CSCM (Fig. 4B) at approximately 1 week after seeding. UM 
cells seeded into Oc. Mel. medium adhered and grew as an 
adherent monolayer in all 13 UM cases monitored. In Figure 
4A, amelanotic spindle cells can be seen around the melanotic 
tumor piece (white arrows). Over time, all cells in culture 
appear to be amelanotic spindle cells (Fig. 4C). In contrast, 
UM cells seeded into CSCM grew as nonadherent spheres and 
remained highly melanotic over long-term culture. These 
spheres were termed ‘‘melanospheres’’ and cycled at a much 
slower rate in comparison to their amelanotic Oc. Mel. 
counterparts.
To determine whether UM cells were able to switch their 
phenotype in response to environmental variations, as 
represented by different media, we reseeded UM cells, 
cultured exclusively in Oc. Mel. medium for between 3 and 
12 months directly from the tumor, into CSCM. All cells in 
culture exhibited an adherent amelanotic phenotype (Fig. 4C) 
at the point before reseeding into CSCM. Cells were pelleted, 
washed with PBS, and subsequently reseeded into fresh CSCM. 
Following introduction into CSCM, UM-adherent cells detached 
and formed spheres (Fig. 4D), and produced melanin within 1 
month in CSCM culture. By approximately 3 months, very few 
adherent cells could be seen and all cells continued to grow as 
melanospheres. To determine whether this phenomenon of 
phenotypic switching was reversible, we reseeded these 
melanospheres back into Oc. Mel. medium. We observed that 
melanospheres that had been exclusively cultured in CSCM 
from surgery readily attached and downregulated melanin 
production within 1 week of exposure to Oc. Mel. medium 
(Fig. 4F). This capacity to switch melanin on and off and
change between adherent and nonadherent was observed in all
UM STCs tested.
To determine whether this plastic phenotype is exclusive to
UM STCs or whether established cell lines also retain a degree
of phenotypic plasticity, we seeded UM cell lines SOM157d and
SOM196b into CSCM and observed their behavior. In standard
Oc. Mel. Medium, these cells grow as adherent amelanotic
spindle-like cells (Fig. 5A); however, when reseeded into
CSCM, melanospheres were observed as early as 2 to 3 days
after seeding. To determine whether these UM cell lines
cultured as melanospheres for an extended period could
readily reverse back to an adherent amelanotic phenotype as
observed in Oc. Mel. medium, cells were cultured in CSCM for
2 months (Fig. 5B). No adherent cells were observed in culture
at 2 months after seeding. Melanospheres were harvested at 2
months, washed in PBS to remove any residual CSCM, and
subsequently seeded into Oc. Mel medium. Within 3 days,
melanospheres could be seen to adhere down and amelanotic
adherent cells were observed (Fig. 5C). After 1 week, these
adherent amelanotic cells had overgrown in culture and
melanospheres could no longer be observed. Both SOM157d
and SOM196b cells behaved in this way, indicating that
established UM cell lines, like UM STCs, retain a degree of
phenotypic plasticity in culture.
DISCUSSION
Tumor progression in cancers such as prostate, colon, breast,
and leukemia has been shown to be driven by a rare
subpopulation of CSCs. Hence, considerable efforts have been
made to identify and target this small subpopulation. In
melanoma, however, the CSC hypothesis remains controversial,
as CM cells, regardless of the expression of stem cell markers,
have been shown to be capable of initiating tumors in
immunocompromised mice.25,26 For example, both CD133þ
and CD133 cells from metastatic CM cell lines are reported as
FIGURE 3. UM cell lines are not organized in a hierarchical manner. When seeded at clonal density, UM cell lines SOM 157d (A) and SOM 196b (B)
readily give rise to colonies. When isolated from culture, all colonies were able to give rise to subsequent colonies, which continued to proliferate.
In both cell lines, all subsequent daughter colonies resembled the parent colony. There was no difference in morphology or proliferative capacity in
daughter colonies.
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equally able to give rise to tumors in vivo,48 whereas in
contradictory studies only CD133þ CM cells exhibited tumori-
genic capacity.18,19 Less is known about the existence of CSCs in
UM, but a previous study found evidence of CSCs in cell lines
from a paired primary and metastatic UM using a clonogenic
assay to identify a cellular hierarchy.45 The study presented here
in UM STCs and cell lines SOM 157d and SOM 196b found no
evidence to support a CSC hypothesis based on expression of the
putative melanoma stem cell markers chosen and an absence of a
cellular hierarchy in the cell lines studied. The marker expression
FIGURE 4. Phenotypic plasticity in UM STCs. (A) UM STC SOM 585 seeded directly from the tumor into Oc. Mel. medium. Image represents 2 weeks
after seeding. Arrows indicate adherent amelanotic cells in contrast to the dense melanotic tumor piece. (B) SOM 585 cells seeded directly into
CSCM from the tumor 2 weeks after seeding. Cells grew as nonadherent melanospheres. (C) Adherent amelanotic UM STC cells cultured in Oc. Mel.
medium for more than 12 months before seeding into CSCM. (D) Cells 1-month post reseeding into CSCM. Melanospheres can be seen to be forming
(black arrows and inset). (E) UM STC cells cultured in CSCM for 11 months before seeding into Oc. Mel. medium growing as melanospheres. (F)
One week post reseeding into Oc. Mel. medium melanospheres had adhered and switched off melanin production. Within 3 weeks, no
melanospheres were observed in culture and all cells grew as amelanotic adherent cells. Scale bar: 200 lM.
FIGURE 5. UM cell lines also retain a plastic phenotype reflective of UM STCs. SOM 157d cells originally maintained in Oc. Mel. medium (A) were
reseeded into CSCM. All cells could be seen to grow as melanospheres within 1 month of seeding (B). After 2 months in CSCM, SOM 157d cells were
subsequently reseeded into Oc. Mel. medium. (C) After 3 days, cells reverted to an adherent phenotype and amelanotic cells were seen to grow
outward from melanospheres. All cells appeared amelanotic following 7 days’ reintroduction to Oc. Mel. medium.
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data presented here suggest that in contrast to other solid
tumors, expression of ALDH and CD44 does not select for a
subpopulation of putative CSCs. The data in ALDHþ populations
in UM STCs supports previous work in CM and suggests an
alternative role for ALDH expression in these cancers.27
The changeable behavior of both established and STC UM
cells demonstrated here supports the hypothesis that UM is able
to undergo phenotypic plasticity. We observed that all cells in
culture are able to undergo the phenomenon of phenotype
switching; supporting previous data in CM and noncancerous
melanocytes that these neuroendocrine derivative cell types
retain a plastic phenotype and readily adapt in response to their
environment.49,50 Previous studies have shown that fully
differentiated melanocytes produce melanin, whereas melano-
cyte precursors are amelanotic.51 Changes in melanin produc-
tion could therefore signal and correlate with dedifferentiation
into a precursor state. In this study, UM cells cultured in the
presence of 20% FCS grew as amelanotic, highly proliferative
cells. The production of melanin by UM cells is, however, not
likely to be the only indication of dedifferentiation and may just
signify the plasticity of UM cells in response to specific culture
conditions. In this study, UM cells cultured in serum-free
conditions were found to readily produce melanin and grow
as melanospheres. The development of melanospheres demon-
strated here mirrors the findings of Zabierowski and col-
leagues52 when studying neural crest stem cell precursors.
Zabierowski and colleagues52 determined that activation of the
Notch1 pathway alone was capable of reprogramming fully
differentiated melanocytes into neural crest stem cell precur-
sors. These precursor cells, like the UM cells in this study, grew
as nonadherent spheres under stem cell culture conditions. It
would therefore seem that UM cells, regardless of cultural
conditions, retain features reminiscent of melanocyte precur-
sors. As further confirmation of this innate ability to be
reprogrammed, other studies have found that normal cutaneous
melanocytes, as well as CM cells, can dedifferentiate into
multipotent self-renewing cells in response to exposure to
endothelin-1, endothelin-3, and OCT4.34,50,53 We therefore
hypothesize that cultured cells derived from primary UM also
retain the capacity to dedifferentiate, as they too are derived
from multipotent, transient neural crest cells, and so their future
behavior is not fixed. Ultimately, it seems likely that their
inherent changeable phenotype may explain why hierarchical
CSCs have not been conclusively identified in UM.
In the present study, we could not identify a CSC
population in UM with the markers selected, and although
some UM cell lines may have a hierarchal organization, our
evidence suggests that in STCs, most cells retain a high degree
of plasticity, reminiscent of a precursor state.
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